8-K: Safety Shot Announces Positive Clinical Trial Results Showing Significant Reduction in Blood Alcohol Content

Safety Shot, Inc. has released results from a clinical trial demonstrating a significant reduction in blood alcohol content (BAC) in participants who consumed their dietary supplement.

Summary

• Safety Shot, Inc. announced results from a double-blind, randomized, placebo-controlled clinical trial conducted at The Center for Applied Health Sciences (CAHS).
• The study evaluated the impact of Safety Shot on blood alcohol content (BAC) and found a significant reduction in BAC in participants who consumed the supplement.
• Participants between 24 and 46 years old, with body weights between 95 and 225 lbs, showed a 30%-50% faster rate of alcohol reduction compared to the placebo group.
• The study also showed improvements in breath alcohol content, and key markers related to alcohol metabolism.
• Participants reported less head discomfort, reduced fatigue, increased energy, improved concentration, and reduced tiredness.
• The results are being compiled into a manuscript for submission to a biomedical journal for peer review and publication.

Sentiment

Score: 8

Explanation: The document presents very positive clinical trial results, suggesting a strong potential for the product. The language used is optimistic and confident, indicating a positive outlook for the company.

Positives

• The clinical trial results showed a statistically significant reduction in BAC.
• The product demonstrated a faster rate of alcohol reduction compared to a placebo.
• Participants reported improvements in physical and cognitive well-being after consuming Safety Shot.
• The company is planning to submit the study results for peer review and publication in a biomedical journal.
• Safety Shot is being introduced to distributors, retailers, restaurants and bars throughout 2024.

Risks

• The company's ability to develop and commercialize the product is subject to risks and uncertainties.
• The company's ability to comply with applicable U.S. and foreign laws, rules, and regulations is a risk.
• Product liability claims are a potential risk.
• The company's future results of operations or financial condition are subject to risks and uncertainties.

Future Outlook

The company plans to continue developing and commercializing Safety Shot, and is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars throughout 2024.

Management Comments

• David Sandler, Chief Operations Officer and co-inventor, stated that the study successfully confirmed what they have seen in non-clinical trials.
• David Sandler said that these results are revolutionizing the wellness space.
• Dr. Tim Ziegenfuss, CEO of CAHS, stated that the results are highly encouraging and showcase Safety Shot's potential as a beneficial supplement for individuals consuming alcohol.

Industry Context

This announcement positions Safety Shot as a potential disruptor in the wellness and dietary supplement industry, specifically targeting the reduction of alcohol effects. The company is aiming to provide a safer experience for consumers of alcohol.

Comparison to Industry Standards

• The study's use of a double-blind, randomized, placebo-controlled design is a gold standard in clinical research, suggesting a high level of rigor.
• The reported 30-50% faster reduction in BAC is a significant result compared to typical alcohol metabolism rates.
• The company is positioning itself against traditional methods of dealing with alcohol consumption, such as waiting for the body to naturally metabolize alcohol.

Stakeholder Impact

• Shareholders may react positively to the clinical trial results.
• Consumers may be interested in the product as a way to reduce the effects of alcohol.
• Distributors, retailers, restaurants and bars may be interested in carrying the product.

Next Steps

• The company will submit the study results to a biomedical journal for peer review and publication.
• The company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars throughout 2024.

Key Dates

Keywords

Safety Shot, Blood Alcohol Content, BAC, Clinical Trial, Alcohol Metabolism, Dietary Supplement, Wellness, Alcohol Reduction